Glucose-dependent insulinotropic polypeptide (GIP)
Showing 1 - 25 of >10,000
Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide
Recruiting
- Type 2 Diabetes
- Obesity
- Semaglutide 1.34 MG/ML [Ozempic]
- +3 more
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
May 19, 2022
Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)
Recruiting
- Blood Flow
- GIPR antagonist / study tool
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Nov 2, 2022
Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )
Recruiting
- Type1diabetes
- +2 more
- Infusion of GIP[1-42], GIP[1-30] or placebo
-
Hellerup, Copenhagen, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023
Acromegaly Due to Pituitary Adenoma Trial in Copenhagen (GIP-A, Placebo)
Recruiting
- Acromegaly Due to Pituitary Adenoma
- GIP-A
- Placebo
-
Copenhagen, DenmarkDepartment of Biomedical Sciences
Nov 1, 2022
Postural Tachycardia Syndrome (POTS) Trial in Nashville (Measurement of Splanchnic venous capacitance(SVC))
Not yet recruiting
- Postural Tachycardia Syndrome (POTS)
- Measurement of Splanchnic venous capacitance(SVC)
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 8, 2022
Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)
Completed
- Bariatric Surgery
- Placebo
- +3 more
-
Hvidovre, Denmark
- +1 more
Jan 31, 2022
Type2 Diabetes Trial in Hellerup (Placebo, GIP receptor antagonization)
Active, not recruiting
- Type2 Diabetes
- Placebo
- GIP receptor antagonization
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Sep 16, 2021
Healthy Trial in Hvidovre (Glucagon-Like Peptide-2 (GLP-2), Glucose-dependent insulinotropic polypeptide (GIP), GLP-2+GIP)
Completed
- Healthy
- Glucagon-Like Peptide-2 (GLP-2)
- +3 more
-
Hvidovre, DenmarkHvidovre University Hospital
Jan 14, 2021
Type2 Diabetes Trial in Copenhagen (Placebo, GIP receptor antagonist, DPP-4 inhibitor)
Completed
- Type2 Diabetes
- Placebo
- +3 more
-
Copenhagen, Hellerup, DenmarkCenter for Clinical Metabolic Research
Mar 15, 2021
Pancreatectomy; Hyperglycemia Trial in Hellerup (Intravenous infusion)
Not yet recruiting
- Pancreatectomy; Hyperglycemia
- Intravenous infusion
-
Hellerup, DenmarkClinical Metabolic Physiology
Dec 14, 2021
Diabetes, Type 1 Trial in Hellerup (glucose-dependent insulinotropic peptide, Glucose-Dependent Insulin-Releasing Hormone[3-30],
Completed
- Diabetes Mellitus, Type 1
- glucose-dependent insulinotropic peptide
- +2 more
-
Hellerup, DenmarkSteno Diabetes Center Copenhagen, Clinical Metabolic Physiology
May 5, 2021
Diabetes, Type 1, Hypoglycemia Trial in Hellerup (GIP)
Completed
- Diabetes Mellitus, Type 1
- Hypoglycemia
-
Hellerup, DenmarkSteno Diabetes Center CopenhagenSteno Diabetes Center Copenhagen
Jan 23, 2020
Obesity, Diabetes, Type 2, Metabolic Syndrome Trial (Cola beverage with aspartame and acesulfame K, Cola beverage with sucrose
Completed
- Obesity
- +2 more
- Cola beverage with aspartame and acesulfame K
- Cola beverage with sucrose and stevia
- (no location specified)
Dec 8, 2022
Obesity, Weight Loss Trial in Birmingham (Empagliflozin Arm, Control Arm, Exercise capacity VO2 maximum determination)
Not yet recruiting
- Obesity
- Weight Loss
- Empagliflozin Arm
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
May 22, 2023
Overweight or Obesity Trial in Chicago (Moona Device)
Not yet recruiting
- Overweight or Obesity
- Moona Device
-
Chicago, IllinoisUniversity of Chicago
Apr 27, 2023
Type 2 Diabetes Trial in Hellerup (Sevelamer, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Sevelamer
- Placebo
-
Hellerup, DenmarkSteno Diabetes Center Copenhagen, Gentofte Hospital
Oct 12, 2021
PCOS Trial in Montréal (Ketone, Water)
Not yet recruiting
- PCOS
- Ketone
- Water
-
Montréal, Quebec, CanadaCardiovascular Health and Autonomic Research Laboratory
Dec 1, 2023
Healthy Trial (Amino acid bolus infusion)
Not yet recruiting
- Healthy
- Amino acid bolus infusion
- (no location specified)
Jul 12, 2023
Type 2 Diabetes, Obesity Trial in Turku (Roux-en-Y, GIP-infusion, GLP-1)
Completed
- Type 2 Diabetes
- Obesity
- Roux-en-Y
- +4 more
-
Turku, FinlandTurku univercity hospital, PET center
Oct 12, 2021
Postprandial Lipemia, Postprandial Glycemia, Gastric Emptying Trial in Kajang (HGI+palm olein, LGI+palm olein, HGI+soy bean oil)
Recruiting
- Postprandial Lipemia
- +2 more
- HGI+palm olein
- +3 more
-
Kajang, Selangor, MalaysiaMalaysian Palm Oil Board
Jul 28, 2023
Idiopathic Ketotic Hypoglycemia Trial in Hellerup (Oral glucose tolerance test, Mixed meal test)
Active, not recruiting
- Idiopathic Ketotic Hypoglycemia
- Oral glucose tolerance test
- Mixed meal test
-
Hellerup, Copenhagen, DenmarkCenter for Clinical Metabolic Research, Department of Medicine,
Mar 25, 2022
Spinal Cord Injuries Trial in Hvidovre (Meal test, GIP, GLP-2)
Recruiting
- Spinal Cord Injuries
- Meal test
- +4 more
-
Hvidovre, DenmarkHvidovre University Hospital
Dec 18, 2021
Type 2 Diabetes Trial in Odense (Low carbohydrate)
Recruiting
- Type 2 Diabetes
- Low carbohydrate
-
Odense, DenmarkOdense University Hospital
Aug 10, 2022
Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)
Not yet recruiting
- Type 2 Diabetes
- Diabetes Mellitus, Type 2
- (no location specified)
Feb 6, 2023